Select a treatment and your primary concern, then click Compare to see detailed insights.
Most clinically proven oral treatment for male-pattern hair loss. Blocks DHT production by 70% with 1mg daily dose.
Sexual Side Effects $30/month High EffectivenessStronger DHT suppression (up to 90%) but higher risk of sexual side effects. Off-label use at 0.5mg daily.
Higher Side Effects $45/month Very High EffectivenessPlant-derived extract with mild 5-alpha-reductase inhibition. Good for early-stage thinning with minimal side effects.
Minimal Side Effects $20/month Moderate EffectivenessVasodilator that prolongs growth phase. Can be combined with any oral treatment. Applied twice daily.
Scalp Irritation $25/month Moderate EffectivenessFinrest is the brand name for finasteride, a 5‑alpha‑reductase inhibitor that reduces dihydrotestosterone (DHT) levels in the scalp. It was first approved by the FDA in 1997 for benign prostatic hyperplasia and later received a 1mg dosage approval for androgenetic alopecia in men. By blocking the enzyme that converts testosterone to DHT, Finrest helps shrink miniaturized hair follicles, slowing hair loss and often regrowing thin strands over 6‑12months.
The drug targets the typeII isoform of the 5‑alpha‑reductase enzyme. DHT is the main hormone that shortens the anagen (growth) phase of hair follicles on the vertex and front scalp. When DHT levels drop about 70% after a daily 1mg dose, follicles receive a healthier hormonal environment, allowing thicker hairs to emerge. The effect is systemic, so the medication is taken orally, usually with a glass of water.
While Finrest remains the gold standard for oral therapy, several alternatives exist. Below, each option is introduced with its own micro‑data definition to aid search engines.
Dutasteride is a dual 5‑alpha‑reductase inhibitor that blocks both typeI and typeII enzymes, delivering up to 90% DHT reduction. It’s FDA‑approved for enlarged prostate but used off‑label for hair loss at 0.5mg daily. The stronger suppression can translate to faster thinning reversal, yet the broader enzyme block often raises the incidence of libido and erectile concerns.
Saw palmetto is a fruit‑derived extract that weakly inhibits 5‑alpha‑reductase, especially the typeII variant. Typical doses range from 160mg to 320mg per day in capsule form. Clinical trials show 10‑15% improvement in hair density, making it a gentle, over‑the‑counter option for early‑stage thinning.
Minoxidil is a topical vasodilator originally developed for hypertension. In a 5% solution for men, it prolongs the anagen phase and increases follicle size. Because it works without hormone modulation, it can be layered under any oral drug, but results usually appear after 4‑6months of twice‑daily application.
Spironolactone is a potassium‑sparing diuretic that also antagonizes androgen receptors. Though rarely prescribed to men because of feminizing side effects, it’s common in women with hormonal hair loss, often at 50‑100mg daily.
Ketoconazole is an antifungal shampoo that reduces scalp inflammation and may modestly inhibit 5‑alpha‑reductase. A 2% formulation used twice a week can add 5‑10% extra hair count when paired with oral treatment.
Pumpkin seed oil is a cold‑pressed oil rich in phytosterols, which are thought to block DHT binding at the follicle level. Studies on 400mg daily capsules report a 10‑12% increase in hair count after 24weeks, positioning it as a low‑risk natural adjunct.
Attribute | Finrest (Finasteride) | Dutasteride | Saw Palmetto | Minoxidil (Topical) | Spironolactone | Ketoconazole Shampoo | Pumpkin Seed Oil |
---|---|---|---|---|---|---|---|
Mechanism | TypeII 5‑α‑reductase inhibitor | Dual typeI &II inhibitor | Weak typeII inhibitor (plant extract) | Vasodilator; prolongs anagen phase | Androgen‑receptor antagonist | Antifungal; mild 5‑α‑reductase inhibition | Phytosterol DHT blocker |
FDA status (hair loss) | Approved (1mg) | Off‑label | Supplement (OTC) | Approved (5%) | Off‑label (women) | OTC (2% shampoo) | Supplement (OTC) |
Typical dose | 1mg daily | 0.5mg daily | 160-320mg daily | 1mL twice daily | 50-100mg daily | Twice weekly wash | 400mg daily |
Hair‑count improvement (clinical avg.) | ≈25% over 12mo | ≈30% over 12mo | ≈12% over 6mo | ≈15% over 6mo | ≈20% (women only) | ≈8% when combined | ≈10% over 24wk |
Common side effects | Reduced libido, erectile dysfunction, ejaculatory delay | Higher incidence of sexual side effects; occasional breast tenderness | Mild GI upset, rare headache | Scalp irritation, itching | Menstrual irregularities, breast tenderness | Dryness, occasional itching | None reported in trials |
Average monthly cost (US$) | ≈30 (generic) | ≈45 (generic) | ≈20 | ≈25 (brand) | ≈15 | ≈12 (OTC shampoo) | ≈18 |
Think of the decision as a checklist of three pillars: effectiveness, tolerance, and practicality.
In practice, many clinicians start patients on Finrest, add minoxidil after three months, and keep a low‑dose ketoconazole shampoo on hand for scalp health. If a patient reports persistent sexual dysfunction, they may switch to dutasteride at a reduced dose or step down to saw‑palmetto.
Finrest’s most discussed risk is post‑finasteride syndrome (PFS), a controversial set of persistent sexual and mood changes after stopping the drug. While incidence is low (<2% in large cohort studies), it’s enough to merit a trialperiod of 3‑6months before committing long‑term.
Dutasteride shares the same hormonal pathway but hits both enzyme isoforms, which can increase the prevalence of erectile issues to roughly 4% in meta‑analyses. The extra efficacy is often not worth the extra risk for men under 30.
Natural alternatives like saw‑palmetto and pumpkin seed oil report negligible systemic side effects, but their modest efficacy means they are best paired with a proven treatment rather than used solo.
Topical minoxidil can cause scalp irritation and, rarely, unwanted facial hair (especially in women). Using a gentle moisturizer or switching to a foam formulation reduces irritation in 80% of users.
Finrest’s generic version costs about $30 a month in the US, and many UK pharmacies carry it for £8‑£12 per 30‑tablet pack under the NHS prescription scheme, making it affordable for long‑term use.
Dutasteride’s generic price is higher, partly because fewer manufacturers produce it. In the UK, it’s generally a private prescription, ranging from £35‑£45 per month.
OTC options-saw‑palmetto capsules, pumpkin seed oil, and ketoconazole shampoo-are widely available in supermarkets and health stores. Their monthly outlay rarely exceeds $20, but remember they’re adjuncts, not stand‑alone cures.
Start with a 3‑month trial of Finrest at the standard 1mg dose. Track progress with weekly photos and note any side effects. If after 12weeks you see no change or experience bothersome sexual symptoms, consider switching to dutasteride at 0.5mg or adding a natural supplement like saw‑palmetto.
For women or men who cannot tolerate any oral anti‑androgen, shift focus to topical therapies (minoxidil, ketoconazole) and hormonal blockers like spironolactone (women only). Consistency is key-most treatments need at least six months of daily use before measurable growth appears.
No. Both drugs suppress the same hormone pathway, so combining them offers no extra benefit and raises the risk of side effects. Choose one or the other based on how strong DHT reduction you need.
It’s safe for most people, but its DHT‑blocking power is much weaker. Expect only modest improvement, making it better as an adjunct or for those who cannot handle prescription meds.
Most users notice a slowdown of hair loss within 3months and visible regrowth after 6‑12months. Patience and consistent daily dosing are essential.
Large cohort studies show no increase in prostate cancer risk when used at the 1mg dose. The main concern is persistent sexual or mood changes in a minority of users, which should be discussed with a physician.
Yes. Some people stop oral therapy once they’ve achieved a stable hair count and maintain results with minoxidil alone. Keep an eye on any renewed shedding during the transition period.
Anastasia Petryankina
October 10, 2025 AT 16:13Oh, because we all needed another glossy chart to decide whether to lose hair or lose our wallets.